Introduction

40
Streptococcus pneumoniae, or pneumococcus, is a Gram-positive bacterium that 41 is a major cause of morbidity and mortality in infants, toddlers and the elderly in both 6 samples. As shown in Figure 1 , there was an age-dependent, significant increase in IL-
119
17A responses (p=0.0235, r=0.3996) and r=0.3786) . The finding that 120 immune responses to pneumococcus in adenoids in children tend to increase with age 121 supports the hypothesis that these adenoidal cells may represent a good source of 122 responsive immune cells for antigen discovery. 
127
Due to the limited number of cells obtained from each adenoid, we were able to screen 128 all 56 proteins in 13 samples and only a subgroup of these proteins with the other 22 129 human samples. Both we and others have showed that IL-17A production in human in 130 response to pneumococcal whole cell or purified pneumococcal proteins are mostly due 131 to stimulation of memory T cells (26, 27) . The results of IL-17A and IL-22 production in 132 these 13 samples after subtracting the baseline responses following incubation with 133 medium alone are shown in Figure 2 . IL-17A responses from each protein were 134 generally in the range of 50-100 pg/ml (mean 157 pg/ml), with WCA having the highest 135 responses (far right) ( Figure 2A ). IL-22 responses were generally higher than IL-17A, 136 mostly ranging from 200-600 pg/ml ( Figure 2B ).
137
Screening antigens using murine immune cells 138 While colonization and infection models in mice are widely used to test candidate 139 pneumococcal vaccines, the extent to which murine immune responses mimic human 140 responses is still unclear. A comparison of the responses of murine and human immune 141 cells following stimulation with proteins from the same pneumococcal library may 142 improve our understanding of the differences between and common features of these 143 two species. To this end, murine splenocytes were obtained from mice either 7 immunized with SPWCV or previously colonized with a serotype 6B pneumococcal strain 145 for 4 weeks (the latter model may more closely mimic pneumococcal exposure in 146 humans). Both methods result in the generation of protective and antigen-specific 147 memory CD4+ T cell responses against nasopharyngeal colonization in mice (3, 13, 28, 148 29), and we have confirmed that these mice were protected from nasal colonization 149 (data not shown). IL-17A responses following stimulation of splenocytes from these two 150 mice models with the library of proteins are shown in Figure 3 . Stimulation with SPWCA 151 and proteins in splenocytes from naïve mice did not generate any IL-17A (data not 152 shown). Responses in SPWCV immunized mice, most of which were between 50 and 153 200 pg/ml ( Figure 3A ) were generally lower than those in pneumococcus-exposed mice, 154 most of which were between 100 and 500 pg/ml ( Figure 3B ). SPWCA induced the 155 largest responses in both mouse models (far right data points).
156
Evaluation of antigens in colonization models. Next, we tested the ability of the 157 library of proteins to provide protection against colonization in mice when used as 158 immunogens. Mice were immunized intranasally twice at a one-week interval with one of 159 the top 5 murine proteins (10 µg/dose) and 1µg of CT; control mice received 1 µg of CT 160 alone. The whole library was tested in six different experiments, as shown in Figure 4 . A 161 total of 18 constructs (16 antigens) was found to be protective in this model; their 162 identities and predicted functions are listed in table 1.
163
Protection against colonization is IL-17A dependent
164
We have shown previously that protection against colonization is dependent on CD4+
165
Th17 cells whereas antibodies directed against antigens contained in the whole cell 166 vaccine were not protective in the colonization model (3, 13, 28) . We then tested 167 whether the protection afforded by these antigens is dependent on IL-17A production. To 168 facilitate the experiment, we chose combinations of the three antigens which induced 169 greatest responses either in murine screens (SP0648-3, SP0757 and SP1500) or in the 170 8 human IL-17A screen (SP0648-1, SP0662-1 and SP0742) and tested the dependence of 171 protection on IL-17A. Mice were immunized intranasally and were given either anti-IL17A 172 antibody or an isotype control antibody both one day before and 3 days after challenge 173 inoculation with S. pneumoniae. As shown in Figure 5 , immunization with both antigen 174 combinations ( Figure 5A 
177
Ranking of antigens and correlation between screens
178
Proteins were ranked in each screen as explained in the methods section. We compared 179 the ranking results of SPWCV-immunized mice, pneumococcal exposed mice and 180 human samples with respect to IL-17A and IL-22. There was a weak correlation between 181 the results from immune cells in the two different mouse models ( Figure S1A ) while 182 there was a strong positive correlation between the IL-17A and IL-22 screens using 183 human cells ( Figure 6 ). No statistically significant correlation was found between the IL-
184
17A screen results using human cells and cells from SPWCV-immunized mice (Figure 185 S1B) or mice previously exposed to pneumococcus ( Figure S1C ), nor was any 186 correlation between human cell IL-22 production and either mouse screen found (data 187 not shown).
188
Validation of the screening method
189
We analyzed how well each screen predicted protection against colonization. Overall, 190 the rate of protection among the proteins in the library is quite high (18/56, 32.1%; Figure   191 4) comparing to regular screening with whole genome (21), which probably reflects the 192 way the library was designed. Antigens were categorized as belonging either to the top 193 or bottom 50%, based on their rankings in each screen. We then compared the "hit rate" 194 (i.e. identifying an antigen that is protective in the colonization model) in the top 50% 195 responders versus the bottom 50% responders in the two murine and one human IL-17A 196 9 screens. While the hit rates were higher in the top 50% responders, none of these 197 differences was significant (table 2) . In contrast, when we identified antigens that were 198 highly ranked either in two screens or amongst all three screens, the hit rates were 199 significantly higher: for example, for antigens that were in the top 50% rank in all three 200 screens, the hit rate was 61.5%, significantly higher than the 11.1% hit rate for antigens 201 that fall into the bottom 50% in all three screens (p=0.0306 by Fisher's exact test), and 202 about twice the hit rate for the whole library, which trended towards significance (p=0.06,
203
by Fisher's). When the same analysis was done with two murine and human IL-22 204 screen, a similar result was obtained. The hit rate in the top 50% rank in all three 205 screens was 58.5%, comparing to 8.3% in the bottom of all three screens (p=0.009).
206
Discussion
207
Using a conserved pneumococcal surface protein library, we stimulated human 208 and murine immune cells in order to identify antigens that elicit IL-17A and IL-22 209 responses and tested which of them confer protection against pneumococcal 210 colonization following intranasal immunization in mice. Overall, we found that antigens 211 that more consistently induced cytokine responses across both murine and human cell 212 screens were more likely to be protective . In addition, we identified many antigens that 213 showed IL-17A-dependent protection against pneumococcal colonization in mice.
214
One goal of this study was to investigate whether the immune responses to 215 pneumococcus in murine and human cells are correlated and whether murine screens 216 could predict the results of the human screen. IL-17A and IL-22 responses of human 217 cells were highly correlated to each other, which confirms our previous findings that IL-
218
17A and IL-22 responses to WCA in children's PBMC are highly correlated (6). However,
219
there was no correlation between the rankings of the IL-17A responses to our protein 220 library in murine and human screens, suggesting that there are differences in responses 221 that are both host-(mouse vs. human) and exposure-dependent (live vs. killed bacteria).
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The lack of correlation between exposed mouse and human cells could be 223 explained by many factors. First, there are clear differences between mouse and human 224 immune systems (30). Furthermore, the local environment for pneumococcal 225 colonization might not be the same in mice and human, given growing evidence of the 226 influence of microbiota on immune development (31). Thirdly, most children may have 227 been exposed to pneumococcus many times, after which they may have generated high 228 Th17 response to nonprotective proteins whereas the mice were only exposed to 229 pneumococcus or pneumococcal antigens for a short defined period in our experiment.
230
Lastly, in addition to intrinsic differences between mouse and human immune cells, we 231 are comparing human adenoidal mucosal cells to murine splenocytes, cells from very 232 different compartments.
233
Despite these differences, we were able to identify several protective candidates 234 by combining the three screens, which suggests that screening for cytokine production 235 using cells from different sources may be a useful method to identify cytokine-mediated 236 protection. Indeed, we found that the protective hit rate was highest in the pool of 237 proteins that induced higher responses in all the screens. The 16 protective antigens 238 that we identified have not previously been reported as conferring protection, with the 239 single exception of SP1683 which was recently reported as a Th17-dependent antigen 240 which protects against colonization while this manuscript was being preparared (32).
241
While protection against colonization by any single antigen did not approach that of 242 SPWCV in mouse models (Figure 4 ), a combination of three antigens significantly 243 improved the protective efficacy of any individual protein antigen ( Figure 5 ). This 244 suggests that a candidate protein-based vaccine should likely comprise several antigens, 245 to maximize protection and coverage.
246
Another important implication of our work is that immune responses 247 demonstrable in mouse models do not accurately predict those of humans. In light of 248 11 the recent failure of at least two different protein vaccine formulations(33, 34) to provide 249 protection against colonization, one is left wondering whether excessive reliance on 250 mouse models may be responsible. Clearly,murine models are much more convenient 251 and practical for large scale screening and identification of potential candidates, as were 252 performed here. However, prior to performing expensive and time-consuming proof-of-253 concept studies of impact on colonization in toddler or infant subjects, perhaps other 254 approaches that can serve to de-risk the process may be useful. One approach would 255 be to try to establish correlates of protection, by performing longitudinal studies of 256 colonization and systemic T cell responses in children. Another approach may be to test 257 promising candidates in intentional challenge studies in humans (8, 35) . A potential 258 caveat to this strategy is that intentional challenge studies are performed in adults,
259
whereas the intended target population of these vaccines is generally toddlers and 260 infants. However, such studies could still be helpful in providing a gating strategy: 261 impact on carriage density or duration of carriage in a properly powered study of 262 intentionally challenged adult volunteers could be used to decide whether or not to 263 pursue studies of the candidate vaccine in younger subjects.
264
A potential limitation of our study is that children undergoing adenoidectomy, who 265 are the only practical and ethically acceptable source of pediatric NALT, may be 266 immunologically distinct from a randomly selected sample of healthy children.
267
Nevertheless, previous studies have confirmed a very similar pattern of acquisition of 268 serum antibodies with age in both these children and healthy controls. Furthermore, 269 rates of pneumococcal colonization at the time of surgery are also similar to those seen 270 in healthy children of comparable age (36). Another potential limitation is that some 271 children may have had limited prior pneumococcal exposure at the time of surgery.
272
However previous studies have shown that the majority of such children have mucosal 273 specific immune responses to pneumococcal protein antigens (37).
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In summary, we report here the results of screening of human and mouse cells 275 following exposure to pneumococcus using a library of conserved pneumococcal 276 proteins. We believe the use of human and murine cells for this type of screening can 277 inform the selection of potential candidates worthy of further study. This approach could 278 also be applied to the identification of other important mucosal pathogens whose route of 279 entry begins in the nasopharynx. 
323
Stimulation of mouse immune cells and human adenoidal cells 324
Splenocytes were harvested from mice that were either immunized with SPWCV 325 intranasally or colonized intranasally with S. pneumoniae strain 0603 (6B serotype) (29).
14 Stimulations were carried out for 3 days with 5 µg/ml of each protein at 37ºC with 5% 327 CO 2 . Plates were then spun to pellet the cells, after which the supernatants were 328 collected and assayed for IL-17A using a mouse IL-17A ELISA kit (R&D Systems, Inc).
329
Human adenoidal mononuclear cells from children undergoing adenoidectomy were 330 separated on Ficoll gradients and cultured at 1x10 6 cells per well in 48 well plates. Cells 331 were stimulated with 8 µg/ml of recombinant proteins or SPWCA at a concentration 332 representing 1x10 6 cfu/ml of killed bacteria for 7 days and supernatants assayed for IL-
333
17A and IL-22 concentrations using human IL-17A and IL-22 ELISA kits (eBioscience). 
346
immunization was done by instilling 20 µl of saline with 1 µg of cholera toxin (CT) as a 347 control, or CT mixed with 10 µg of antigen as specified, atraumatically into 348 unanesthetized mice twice at a one-week interval. Blood was drawn 3 weeks after the 349 last immunization, and assayed for IL-17A production upon stimulation with 5 µg/ml of 350 the corresponding protein for 6 days. Nasopharyngeal colonization with the clinical 351 pneumococcal isolate 0603 (serotype 6B) was carried out as previously described (29 Top 50% responders from ranked screen results of immunized mice (WCV), 536 exposed mice (exposed) and human IL-17A (human). Each screen was ranked and then 537 the top 50% or bottom 50% of proteins in the rankings were selected and overlap 538 between these antigens was shown here. 
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(A) IL-17A levels following stimulation of splenocytes from SPWCV immunized mice. (B)
571
IL-17A levels following stimulation of splenocytes from pneumococcus-exposed mice.
572 Figure 4 . Protection against colonization by antigens from the surface protein library.
573
Mice were immunized with 10 µg of each protein and 1 µg of cholera toxin twice weekly 574 and challenged 4 weeks after the last immunization with a serotype 6B clinical strain.
575
Nasal wash was collected 7 days later and bacterial CFU was determined by plating.
576
Each dot represents CFU recovered from one mouse and the lines for each column 
